HHS has updated the National Public Health Emergency for monkeypox outbreak in the United States. As respiratory disease continues to spread, demand for amoxicillin is in short supply nationwide. A drug already approved for weight loss in adults has shown promise in her teens from age 12 to her 17.
US monkeypox health emergency updated
According to The Hill, HHS has announced it is renewing its national public health emergency for the monkeypox outbreak. Continuing outbreaks in multiple states have been cited as a reason to prolong the declared health emergency, and the need to keep data flowing and allow research into vaccine efficacy to continue. The news comes when new research finds that monkeypox can spread before symptoms appear.
Shortage of Amoxicillin Due to Rising Respiratory Diseases
Amyoxycillin shortages are being caused by an increase in respiratory illnesses among children across the country. Washington PostSome forms of amoxicillin are still available, pharmacists say, but the shortage may require parents to go to multiple pharmacies or accept a different strength or form than was originally prescribed. The shortage has primarily affected the supply of liquid versions and some chewable tablets. The shortage is largely due to the influx of children hospitalized after being diagnosed with her RSV, so the shortage is likely to continue as long as the RSV season lasts.
Weight loss pills help obese teenagers
A clinical trial found that using the appetite suppressant semaglutide (Wegovy) helped obese teens lose weight, according to NBC News. The study found that more than 40% of participants aged 12-17 years who received drug and lifestyle counseling experienced a 20% or more reduction in BMI. It has been found to be beneficial and has been proven to help adults lose weight, and the FDA will approve the drug for weight loss in 2021. The long-term efficacy of the drug has not yet been determined.
.
